The patient monitoring devices market is projected to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022, at a CAGR of 9.1% during the forecast period. The development in this market is largely driven by increased funding, research grants, and public-private investments; ongoing technological developments in the field of wearable technologies; sustained government initiatives to expand healthcare infrastructure in major & emerging markets, and the emergence of user-centric patient monitoring devices. Though, the risk associated with invasive monitoring devices is likely to limit market growth during the coming decade.
The competitive landscape comprises the analysis of the significant growth tactics adopted by key companies from 2020 to 2021 to increase their market shares and grow their global footprint in the patient monitoring devices market space. Most prominent growth strategies adopted by the leading market players include new product approvals, launches, distribution agreements, expansions, and acquisitions. Product launches in new markets and approvals are the most widely implemented growth strategies by companies in the last couple of years to garner an increased share of the market. In 2021, the patient monitoring devices market was dominated by GE Healthcare (US), Medtronic plc (Ireland), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), and Masimo Corporation (US).
To know about the assumptions considered for the study download the pdf brochure
MEDTRONIC PLC (US)
As of 2021, Medtronic plc (US) has a broad range of product offerings in the patient monitoring devices market. Their relevant product portfolio includes respiratory monitoring devices, neuromonitoring, heart monitoring devices, and blood glucose monitoring devices. The company is focused on innovations and improving the quality of its products with increasing investment in its R&D department. The company’s flagship product─BIS brain monitoring system–is among the most widely used systems in the patient monitoring devices market. Medtronic’s global presence allows it to cater to a customer base across 150+ countries such as the the US, UK, Germany, New Zealand, and Australia,.
GE HEALTHCARE (US)
As of 2021, GE Healthcare (US) is among the leading players in the global patient monitoring devices market. GE Healthcare is a pioneer of innovative solutions for patient monitoring devices in various fields such as cardiac monitoring devices, multi-parameter monitoring devices, and neonatal and fetal monitoring products. The high focus on R&D, comprehensive range of products, and strong geographical presence are the key factors contributing to the major market share of the company in the patient monitoring devices market. Along with this heavy investment in R&D is driving the company’s technologically improved products.
Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE